Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021:260:441-451.
doi: 10.1016/bs.pbr.2020.12.005. Epub 2021 Feb 4.

Towards a unification of treatments and interventions for tinnitus patients: The EU research and innovation action UNITI

Winfried Schlee  1 Stefan Schoisswohl  2 Susanne Staudinger  2 Axel Schiller  2 Astrid Lehner  2 Berthold Langguth  2 Martin Schecklmann  2 Jorge Simoes  2 Patrick Neff  2 Steven C Marcrum  3 Myra Spiliopoulou  4 Uli Niemann  4 Miro Schleicher  4 Vishnu Unnikrishnan  4 Clara Puga  4 Lena Mulansky  5 Ruediger Pryss  5 Carsten Vogel  5 Johannes Allgaier  5 Efi Giannopoulou  6 Katalin Birki  6 Klairi Liakou  6 Rilana Cima  7 Johan W S Vlaeyen  7 Nicolas Verhaert  7 Saskia Ranson  8 Birgit Mazurek  9 Petra Brueggemann  9 Benjamin Boecking  9 Nyamaa Amarjargal  9 Sandy Specht  9 Alexandra Stege  10 Michael Hummel  10 Matthias Rose  11 Kevin Oppel  12 Juliane Dettling-Papargyris  12 Jose Antonio Lopez-Escamez  13 Sana Amanat  14 Alvaro Gallego-Martinez  14 Alba Escalera-Balsera  14 Juan Manuel Espinosa-Sanchez  15 Juan Garcia-Valdecasas  16 Maria Mata-Ferron  16 Juan Martin-Lagos  17 Maria Martinez-Martinez  17 María Jesús Martinez-Martinez  16 Nicolas Müller-Locatelli  17 Patricia Perez-Carpena  17 Jorge Alcazar-Beltran  18 Leyre Hidalgo-Lopez  18 Eleftheria Vellidou  19 Michalis Sarafidis  19 Panagiotis Katrakazas  19 Vassileia Kostaridou  19 Dimitris Koutsouris  19 Rano Manta  19 Evangelos Paraskevopoulos  19 Maria Haritou  19 Ana Belén Elgoyhen  20 Hazel Goedhart  21 Michael Koller  22 Giriraj Singh Shekhawat  23 Holger Crump  24 Ronny Hannemann  25 Marc Holfelder  26 Timon Oberholzer  27 Apostolos Vontas  28 Ilias Trochidis  28 Vicky Moumtzi  28 Christopher R Cederroth  29 Konstantina Koloutsou  30 George Spanoudakis  30 Ioannis Basdekis  30 Silvano Gallus  31 Alessandra Lugo  31 Chiara Stival  31 Elisa Borroni  31 Nikolaos Markatos  32 Athanasios Bibas  32 Dimitris Kikidis  32
Affiliations
Randomized Controlled Trial

Towards a unification of treatments and interventions for tinnitus patients: The EU research and innovation action UNITI

Winfried Schlee et al. Prog Brain Res. 2021.

Abstract

Tinnitus is the perception of a phantom sound and the patient's reaction to it. Although much progress has been made, tinnitus remains a scientific and clinical enigma of high prevalence and high economic burden, with an estimated prevalence of 10%-20% among the adult population. The EU is funding a new collaborative project entitled "Unification of Treatments and Interventions for Tinnitus Patients" (UNITI, grant no. 848261) under its Horizon 2020 framework. The main goal of the UNITI project is to set the ground for a predictive computational model based on existing and longitudinal data attempting to address the question of which treatment or combination of treatments is optimal for a specific patient group based on certain parameters. Clinical, epidemiological, genetic and audiological data, including signals reflecting ear-brain communication, as well as patients' medical history, will be analyzed making use of existing databases. Predictive factors for different patient groups will be extracted and their prognostic relevance validated through a Randomized Clinical Trial (RCT) in which different patient groups will undergo a combination of tinnitus therapies targeting both auditory and central nervous systems. From a scientific point of view, the UNITI project can be summarized into the following research goals: (1) Analysis of existing data: Results of existing clinical studies will be analyzed to identify subgroups of patients with specific treatment responses and to identify systematic differences between the patient groups at the participating clinical centers. (2) Genetic and blood biomarker analysis: High throughput Whole Exome Sequencing (WES) will be performed in well-characterized chronic tinnitus cases, together with Proximity Extension Assays (PEA) for the identification of blood biomarkers for tinnitus. (3) RCT: A total of 500 patients will be recruited at five clinical centers across Europe comparing single treatments against combinational treatments. The four main treatments are Cognitive Behavioral Therapy (CBT), hearing aids, sound stimulation, and structured counseling. The consortium will also make use of e/m-health applications for the treatment and assessment of tinnitus. (4) Decision Support System: An innovative Decision Support System will be implemented, integrating all available parameters (epidemiological, clinical, audiometry, genetics, socioeconomic and medical history) to suggest specific examinations and the optimal intervention strategy based on the collected data. (5) Financial estimation analysis: A cost-effectiveness analysis for the respective interventions will be calculated to investigate the economic effects of the interventions based on quality-adjusted life years. In this paper, we will present the UNITI project, the scientific questions that it aims to address, the research consortium, and the organizational structure.

Keywords: Cognitive behavioral therapy; Decision support system; Genetics; Hearing aids; Randomized clinical trial; Sound stimulation; Structured counseling; Tinnitus.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources